Quality & Compliance

With the FDA still behind on inspections, manufacturers need to uncover their own blindspots.

An industry consortium is tackling one of pharma’s biggest drug-related challenges.

Researchers explain how they used video games to explore human behavior when it comes to producing pharma products.

Changes are coming to Annex 1 of the EU’s GMP. What can pharma expect?

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

Simple and efficient systems for continuous monitoring can make all the difference in developing innovative products.

AI is expanding into medicine. Are the world’s regulators ready?

What are the challenges and best practices in quality control for difficult-to-inspect products?

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.